Return on investment of fracture liaison services: a systematic review and analysis
Authors' conclusion
This review revealed a 10.49-fold monetary return of FLS.
Study context
- Population
- Patients with an existing fragility fracture; studies on cost-effectiveness of fracture liaison services (FLS) published January 2000–December 202223 FLS
- Outcome
- Return on investment (ROI) of FLS: (monetary benefits − FLS costs) / FLS costs
Methodological detailssubgroup analysis across FLS types and design details, Searched MEDLINE, EMBASE, PubMed and Cochrane Central, Two independent reviewers for study selection and data extraction
- Subgroup analysis across FLS types and design details
- Searched MEDLINE, EMBASE, PubMed and Cochrane Central
- Two independent reviewers for study selection and data extraction
Pooled result
As reported in the abstract
ROI of FLS
Mean return on investment (ROI)
10.49
Median ROI
7.57
FLS with positive ROI
86.96%
Further pooled results
ROI, FLS making treatment recommendations (highest ROI)
- Mean ROI
- 18.39
- Median ROI
- 13.60
ROI, FLS incorporating primary care providers
- Mean ROI
- 16.04
- Median ROI
- 13.20
ROI, FLS with primary care providers as program leaders
- Mean ROI
- 12.07
- Median ROI
- 12.07
ROI by FLS type
- Intensive type A and B FLS had higher ROI than non-intensive type C and D FLS
- FLS for specific fracture sites had great monetary return
Original publication
Return on investment of fracture liaison services: a systematic review and analysis. Osteoporos Int. Published 1 February 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →